TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharma Systems AB
Closing information (x1000 SEK)
Closing information | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
Turnover |
21,261
|
36,342
|
28,277 |
Financial expenses |
247
|
216
|
5 |
Earnings before taxes |
-3,335
|
344
|
4,030 |
EBITDA |
-2,268
|
2,357
|
4,294 |
Total assets |
23,345
|
22,846
|
32,616 |
Current assets |
16,762
|
15,072
|
28,823 |
Current liabilities |
5,965
|
3,862
|
4,174 |
Equity capital |
14,272
|
14,277
|
24,374 |
- share capital |
206
![]() |
206
![]() |
206 |
Employees (average) |
29
|
34
|
2 |
Financial ratios
Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
Solvency |
61.1%
|
62.5%
|
74.7% |
Turnover per employee |
733
|
1,069
|
14,138 |
Profit as a percentage of turnover |
-15.7%
|
0.9%
|
14.3% |
Return on assets (ROA) |
-13.2%
|
2.5%
|
12.4% |
Current ratio |
281.0%
|
390.3%
|
690.5% |
Return on equity (ROE) |
-23.4%
|
2.4%
|
16.5% |
Change turnover |
-15,081
|
8,065
|
-8,723 |
Change turnover % | -41% | -24% | |
Chg. No. of employees |
-5
|
32
|
0 |
Chg. No. of employees % | -15% | 0% |
Total value of public sale
Fiscal year | 2024/06 (consolidated) | 2023/06 (consolidated) | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.